DC Cure 1:1 Auto

Description

DC Cure 1:1 – Balanced Autoflower with CBD-Rich Seed Genetics

DC Cure 1:1 is the first autoflowering strain in the Doctor’s Choice lineup bred specifically for a 1:1 THC to CBD ratio. This feminized cannabis seed is ideal for collectors looking for CBD-rich genetics in an easy-to-grow, fast-finishing autoflower format.

The plant grows compact to mid-sized (50–120 cm) and produces dense, sticky buds with a citrus-forward aroma complemented by spicy and earthy undertones. Its life cycle completes in just 60–70 days from seed, making it ideal for indoor setups or discreet outdoor growing with techniques like SCRoG.

Genetically, DC Cure 1:1 combines Chronic Ryder with a CBD-dominant parent, creating a balanced hybrid with stable structure and consistent outcomes. Suitable for indoor, outdoor, and greenhouse environments, this strain is particularly appealing to growers seeking CBD-focused seeds.

While the yield is moderate (around 50 g per plant), the resin quality and cannabinoid ratio make it stand out in any seed collection. Thanks to its forgiving nature, it’s also well-suited for beginners or low-maintenance grows.

Main Features and Benefits

• CBD-rich autoflower strain with a 1:1 cannabinoid profile.
• Fast lifecycle – ready for harvest in just 60–70 days from seed.
• Distinct terpene profile – citrus, spicy, earthy, and resin-heavy.

DC Cure 1:1 is a smart seed choice for collectors who value balanced cannabinoid ratios, compact growth, and fast, reliable cultivation results.

Key facts

• Breeder: Doctor’s Choice
• Seed type: feminized autoflower
• Crossing: Chronic Ryder × CBD-rich plant
• CBD: High
• Cultivation: Indoor, Outdoor and Greenhouse

Cannabis seeds are sold for collection and genetic preservation. Check the law in your country before germinating them.

Sold and shipped by Cannoptikum (Cannoptikum KG, Rinn, Austria). Seeds ship worldwide; grow-shop products ship within the EU. Prices are set by the vendor and you complete your purchase on their site. Adults only.